Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,476 | 4,022 | 1,807 | 2,779 | 5,199 |
| Receivables | 119 | 172 | 119 | 237 | 113 |
| TOTAL | $1,623 | $4,194 | $1,926 | $3,016 | $5,375 |
| Non-Current Assets | |||||
| PPE Net | 163 | 330 | 337 | 479 | 287 |
| TOTAL | $163 | $330 | $337 | $479 | $287 |
| Total Assets | $1,786 | $4,524 | $2,262 | $3,495 | $5,661 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 444 | 411 | 718 | 367 | 543 |
| TOTAL | $824 | $800 | $1,049 | $777 | $1,259 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 6 | 18 | 25 | 50 |
| TOTAL | $0 | $6 | $18 | $25 | $50 |
| Total Liabilities | $824 | $805 | $1,068 | $801 | $1,308 |
| Shareholders' Equity | |||||
| Common Shares | 39,666 | 39,666 | 34,056 | 32,456 | 30,367 |
| Retained earnings | -39,484 | -36,493 | -34,375 | -30,935 | -27,031 |
| Other shareholders' equity | 780 | 545 | 1,514 | 1,174 | 1,016 |
| TOTAL | $962 | $3,719 | $1,195 | $2,694 | $4,353 |
| Total Liabilities And Equity | $1,786 | $4,524 | $2,262 | $3,495 | $5,661 |